MET and neoplasm: The maintenance of tumor stemness in GBM CSCs has been also recently attributed to the activation of c-Met, the tyrosine kinase receptor of the hepatocyte growth factor/scatter factor (HGF/SF), which also seems to mediate the acquisition of GBM CSCs radiotherapy resistance [32].